• Profile
Close

Antibiotic treatment for uncomplicated and mild complicated diverticulitis: Outpatient treatment for everyone

International Journal of Colorectal Disease Aug 18, 2017

Joliat GR, et al. – Authors here assessed the 1–month failure rate of outpatient treatment (OT) for uncomplicated diverticulitis (uD)/mild complicated diverticulitis (mcD) compared to inpatient treatment (IT), and identified predictive factors for treatment failure. They realized the feasibility and safety of outpatient treatment for uncomplicated/mild complicated diverticulitis. Prognostic factors of failure necessitating closer follow–up included admission/CT time, Ambrosetti score of 4, and free air around the colon.

Methods

  • Authors retrospectively analyzed all consecutive patients (2006–2012) diagnosed with uD/mcD by CT scan.
  • They defined acute uD as absence of the following: abscess, fistula, extraluminal contrast, pneumoperitoneum, and need for immediate percutaneous drainage/surgery.
  • Complicated diverticulitis with abscess <4 cm or pneumoperitoneum <2 cm was observed as acute mcD.
  • Antibiotherapy was offered to all patients.
  • They defined treatment failure as (re)hospitalization the first month after treatment onset or need of drainage/surgery during hospitalization.
  • They contacted all patients using a standardized questionnaire.

Results

  • 540 uD/mcD were assessed; IT was offered to 369 patients (68%) and OT to 171 patients (32%).
  • In this study, the IT group indicated higher median age, more women, higher median Charlson Index, more severe median Ambrosetti score, longer median time in the emergency room, and higher median CRP.
  • To the questionnaire, response rates of 56% (IT) vs. 62% (OT) were observed (p = 0.18).
  • Findings revealed failure rates of 32% in IT vs. 10% in OT group, p < 0.01.
  • Among the uD/mcD patients, risk factors for failure included admission/CT time between midnight and 6 AM, Ambrosetti score of 4, and free air around the colon.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay